Compare 10X Genomics Inc (TXG) vs United States Natural Gas Fund (UNG) Price & Performance

TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.

The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.

UNG trades at $10.46, down 0.95% with a bearish technical signal from moving averages. The ETF faces headwinds from high natural gas production and storage levels, though weather-driven demand provides some support. Recent EIA forecasts project record natural gas supply and demand through 2027, creating a mixed fundamental backdrop for this futures-based commodity ETF.

The outlook remains challenged by oversupply concerns, though long-term demand growth from LNG exports and data center power needs offers potential upside. Key risks include commodity price volatility and the structural limitations of futures-based ETFs versus equity-based alternatives like FCG.